NARB Press Releases

NARB Recommends Verizon Modify ‘#1’ Claims to Clarify ‘Customer Satisfaction’ Basis

A panel of NARB has recommended that Verizon Communications, Inc. modify “#1” claims for the company’s FiOS Internet and television service to more clearly communicate the basis for the claims.

Read More

NARB Recommends Clarion Brands Modify, Discontinue Claims That Dietary Supplement ‘Lipo-Flavonoid Plus’ Substantially Reduces, Eliminates Tinnitus

A five-member panel of NARB has recommended that Clarion Brands LLC modify or discontinue certain claims for the company’s Lipo-Flavonoid Plus dietary supplement, including claims made through testimonials, that state or imply that the product substantially reduces or eliminates tinnitus and the symptoms of Ménière’s Disease, a disorder of the inner ear.

Read More

National Advertising Review Board Welcomes 22 New Members From Nation’s Top Companies, Ad Agencies, Universities

NARB has named 22 new members to the advertising industry’s only peer-review process – a body that serves to assure that advertising claims are truthful and accurate.

Read More

NARB Recommends Novartis/GSK Discontinue Claim that Benefiber ‘Helps Maintain Regularity’

A NARB panel has recommended that Novartis Consumer Health, Inc., now a GSK Consumer Healthcare Company, discontinue the claim, made in television and print ads, that its dietary supplement product Benefiber “Helps Maintain Regularity.”

Read More

NARB Panel Recommends Clorox Discontinue Claims Challenged by OxiClean Maker Church & Dwight

A five-member panel of NARB has recommended that The Clorox Company discontinue advertising claims challenged by Church & Dwight Co., the maker of OxiClean White Revive.

Read More

NARB Panel Recommends Bayer Modify, Discontinue Certain Claims for Claritin-D

A five-member panel of NARB has recommended that Bayer HealthCare, LLC discontinue the advertising claim that nothing works faster than Claritin-D and qualify the claim that Claritin-D starts to work on allergies in 30 minutes.

Read More